Real-world pharmacovigilance study on neonatal congenital anomalies associated with maternal drug exposure using the FDA Adverse Event Reporting System
Our research offers a thorough examination of teratogenic risks across different drug categories using data from the FAERS database, which can enhance the safety of medication use during pregnancy and inform clinical decision-making.
Authors
- Lin Ma (ORCID: https://orcid.org/0009-0000-5723-0251)
- Jingping Zheng (ORCID: https://orcid.org/0000-0002-9770-4308)
- Zhenpo Zhang (ORCID: https://orcid.org/0009-0006-8175-4972)
- Ling Su (ORCID: https://orcid.org/0000-0002-0594-9181)
Institutions
- Jinan University (CN)
- Guangdong Pharmaceutical University (CN)
- Guangdong Provincial Hospital of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Therapeutic Advances in Drug Safety
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1177/20420986251383765
- Citations
- 1
- Primary Topic
- Pharmacological Effects and Toxicity Studies
- Type
- article
- Field-Weighted Citation Impact
- 3.49